Brenus Pharma is a series a startup. 1 investor tracked on Brouky Intelligence. Status: possibledead. Data sourced from Brouky Intelligence.
About
Brenus Pharma is a biotechnology company specializing in autologous cell therapy to fight cancer. The company offers a unique approach to cancer treatment by using the patient's own modified immune cells to target and destroy cancer cells.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky